+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

GLP-1 Receptor Agonist Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 73 Pages
  • May 2025
  • Region: Global
  • Prof Research
  • ID: 6090496
Description Jump to:
GLP-1 receptor agonists (GLP-1 RAs), including Ozempic, Trulicity, and Wegovy, manage type 2 diabetes (T2DM, 537 million cases globally) and obesity (424 million adults), with projections of 643 million T2DM cases by 2030. The market is driven by their dual efficacy in glycemic control and weight loss, reducing cardiovascular risks by 15-20%, and high adherence (20% better with weekly injections). Expanded indications, like Wegovy for cardiovascular disease, and novel oral formulations (e.g., Rybelsus) fuel growth. The global GLP-1 RA market is estimated at USD 40-70 billion in 2025, with a CAGR of 13%-18% through 2030.

Regional Market Trends

  • North America: The U.S. leads with high T2DM and obesity rates, while Canada emphasizes preventive care.
  • Europe: Germany, France, and the UK drive growth with robust diabetes management.
  • Asia Pacific: China and India see rising demand due to lifestyle changes, with Japan focusing on oral formulations.
  • Rest of the World: Brazil expands diabetes care, while the Middle East addresses metabolic disorders.

Distribution Channel Analysis

  • Hospital Pharmacies: Expected growth of 13.5%-18.5%, driven by T2DM prescriptions. Trends focus on specialized care.
  • Retail Pharmacies: Projected growth of 13.0%-18.0%, linked to obesity management. Advances emphasize accessibility.
  • Online Pharmacies: Anticipated growth of 14.0%-19.0%, for patient convenience. Trends highlight digital access.

Type Analysis

  • Ozempic: Expected growth of 14.0%-19.0%, valued for glycemic control. Trends focus on cardiovascular benefits.
  • Trulicity: Projected growth of 13.5%-18.5%, suited for weekly dosing. Advances emphasize adherence.
  • Mounjaro: Anticipated growth of 15.0%-20.0%, for dual GIP/GLP-1 action. Trends highlight weight loss efficacy.
  • Wegovy: Expected growth of 14.5%-19.5%, for obesity. Developments prioritize expanded indications.
  • Rybelsus: Expected growth of 15.5%-20.5%, as an oral option. Trends focus on patient preference.
  • Saxenda: Expected growth of 12.5%-17.5%, for weight management. Trends highlight pediatric use.
  • Victoza: Expected growth of 12.0%-17.0%, for T2DM. Developments prioritize combination therapies.
  • Zepbound: Expected growth of 14.0%-19.0%, for obesity. Trends focus on high efficacy.
  • Other Products: Expected growth of 12.0%-17.0%, covering novel agents. Developments prioritize oral innovations.

Key Market Players

  • Novo Nordisk: Offers Ozempic and Wegovy for T2DM and obesity.
  • Eli Lilly: Develops Mounjaro and Trulicity.
  • Sanofi: Focuses on diabetes therapies.
  • AstraZeneca: Provides supportive metabolic treatments.

Porter’s Five Forces Analysis

  • Threat of New Entrants: Low, due to high R&D costs and patent protections.
  • Threat of Substitutes: Moderate, with other diabetes drugs competing, but GLP-1 RAs excel in dual efficacy.
  • Bargaining Power of Buyers: Moderate, with insurers negotiating prices, but high demand limits leverage.
  • Bargaining Power of Suppliers: Low, with multiple API providers.
  • Competitive Rivalry: High, with players competing on efficacy and delivery.

Market Opportunities and Challenges

Opportunities:

  • Addressing T2DM, affecting 537 million people.
  • Managing obesity, impacting 424 million adults.
  • Leveraging cardiovascular benefits, reducing risks by 15-20%.
  • Utilizing oral formulations, improving adherence by 20%.
  • Supporting COVID-19 patients with high T2DM risks.
  • Expanding indications like cardiovascular disease.

Challenges:

  • High costs of GLP-1 RAs limiting access.
  • Regulatory delays for new formulations.
  • Competition from other diabetes therapies.
  • Supply chain constraints for high-demand drugs.
  • Patient adherence issues in low-income regions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Glp-1 Receptor Agonist Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Glp-1 Receptor Agonist Market in North America (2020-2030)
8.1 Glp-1 Receptor Agonist Market Size
8.2 Glp-1 Receptor Agonist Market by End Use
8.3 Competition by Players/Suppliers
8.4 Glp-1 Receptor Agonist Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Glp-1 Receptor Agonist Market in South America (2020-2030)
9.1 Glp-1 Receptor Agonist Market Size
9.2 Glp-1 Receptor Agonist Market by End Use
9.3 Competition by Players/Suppliers
9.4 Glp-1 Receptor Agonist Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Glp-1 Receptor Agonist Market in Asia & Pacific (2020-2030)
10.1 Glp-1 Receptor Agonist Market Size
10.2 Glp-1 Receptor Agonist Market by End Use
10.3 Competition by Players/Suppliers
10.4 Glp-1 Receptor Agonist Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Glp-1 Receptor Agonist Market in Europe (2020-2030)
11.1 Glp-1 Receptor Agonist Market Size
11.2 Glp-1 Receptor Agonist Market by End Use
11.3 Competition by Players/Suppliers
11.4 Glp-1 Receptor Agonist Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Glp-1 Receptor Agonist Market in MEA (2020-2030)
12.1 Glp-1 Receptor Agonist Market Size
12.2 Glp-1 Receptor Agonist Market by End Use
12.3 Competition by Players/Suppliers
12.4 Glp-1 Receptor Agonist Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Glp-1 Receptor Agonist Market (2020-2025)
13.1 Glp-1 Receptor Agonist Market Size
13.2 Glp-1 Receptor Agonist Market by End Use
13.3 Competition by Players/Suppliers
13.4 Glp-1 Receptor Agonist Market Size by Type
Chapter 14 Global Glp-1 Receptor Agonist Market Forecast (2025-2030)
14.1 Glp-1 Receptor Agonist Market Size Forecast
14.2 Glp-1 Receptor Agonist Application Forecast
14.3 Competition by Players/Suppliers
14.4 Glp-1 Receptor Agonist Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Nordisk
15.1.1 Company Profile
15.1.2 Main Business and GLP-1 Receptor Agonist Information
15.1.3 SWOT Analysis of Nordisk
15.1.4 Nordisk GLP-1 Receptor Agonist Revenue, Gross Margin and Market Share (2020-2025)
15.2 Eli Lilly
15.2.1 Company Profile
15.2.2 Main Business and GLP-1 Receptor Agonist Information
15.2.3 SWOT Analysis of Eli Lilly
15.2.4 Eli Lilly GLP-1 Receptor Agonist Revenue, Gross Margin and Market Share (2020-2025)
15.3 Sanofi
15.3.1 Company Profile
15.3.2 Main Business and GLP-1 Receptor Agonist Information
15.3.3 SWOT Analysis of Sanofi
15.3.4 Sanofi GLP-1 Receptor Agonist Revenue, Gross Margin and Market Share (2020-2025)
15.4 AstraZeneca
15.4.1 Company Profile
15.4.2 Main Business and GLP-1 Receptor Agonist Information
15.4.3 SWOT Analysis of AstraZeneca
15.4.4 AstraZeneca GLP-1 Receptor Agonist Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Glp-1 Receptor Agonist Report
Table Data Sources of Glp-1 Receptor Agonist Report
Table Major Assumptions of Glp-1 Receptor Agonist Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Glp-1 Receptor Agonist Picture
Table Glp-1 Receptor Agonist Classification
Table Glp-1 Receptor Agonist Applications
Table Drivers of Glp-1 Receptor Agonist Market
Table Restraints of Glp-1 Receptor Agonist Market
Table Opportunities of Glp-1 Receptor Agonist Market
Table Threats of Glp-1 Receptor Agonist Market
Table COVID-19 Impact For Glp-1 Receptor Agonist Market
Table Raw Materials Suppliers
Table Different Production Methods of Glp-1 Receptor Agonist
Table Cost Structure Analysis of Glp-1 Receptor Agonist
Table Key End Users
Table Latest News of Glp-1 Receptor Agonist Market
Table Merger and Acquisition
Table Planned/Future Project of Glp-1 Receptor Agonist Market
Table Policy of Glp-1 Receptor Agonist Market
Table 2020-2030 North America Glp-1 Receptor Agonist Market Size
Figure 2020-2030 North America Glp-1 Receptor Agonist Market Size and CAGR
Table 2020-2030 North America Glp-1 Receptor Agonist Market Size by Application
Table 2020-2025 North America Glp-1 Receptor Agonist Key Players Revenue
Table 2020-2025 North America Glp-1 Receptor Agonist Key Players Market Share
Table 2020-2030 North America Glp-1 Receptor Agonist Market Size by Type
Table 2020-2030 United States Glp-1 Receptor Agonist Market Size
Table 2020-2030 Canada Glp-1 Receptor Agonist Market Size
Table 2020-2030 Mexico Glp-1 Receptor Agonist Market Size
Table 2020-2030 South America Glp-1 Receptor Agonist Market Size
Figure 2020-2030 South America Glp-1 Receptor Agonist Market Size and CAGR
Table 2020-2030 South America Glp-1 Receptor Agonist Market Size by Application
Table 2020-2025 South America Glp-1 Receptor Agonist Key Players Revenue
Table 2020-2025 South America Glp-1 Receptor Agonist Key Players Market Share
Table 2020-2030 South America Glp-1 Receptor Agonist Market Size by Type
Table 2020-2030 Brazil Glp-1 Receptor Agonist Market Size
Table 2020-2030 Argentina Glp-1 Receptor Agonist Market Size
Table 2020-2030 Chile Glp-1 Receptor Agonist Market Size
Table 2020-2030 Peru Glp-1 Receptor Agonist Market Size
Table 2020-2030 Asia & Pacific Glp-1 Receptor Agonist Market Size
Figure 2020-2030 Asia & Pacific Glp-1 Receptor Agonist Market Size and CAGR
Table 2020-2030 Asia & Pacific Glp-1 Receptor Agonist Market Size by Application
Table 2020-2025 Asia & Pacific Glp-1 Receptor Agonist Key Players Revenue
Table 2020-2025 Asia & Pacific Glp-1 Receptor Agonist Key Players Market Share
Table 2020-2030 Asia & Pacific Glp-1 Receptor Agonist Market Size by Type
Table 2020-2030 China Glp-1 Receptor Agonist Market Size
Table 2020-2030 India Glp-1 Receptor Agonist Market Size
Table 2020-2030 Japan Glp-1 Receptor Agonist Market Size
Table 2020-2030 South Korea Glp-1 Receptor Agonist Market Size
Table 2020-2030 Southeast Asia Glp-1 Receptor Agonist Market Size
Table 2020-2030 Australia Glp-1 Receptor Agonist Market Size
Table 2020-2030 Europe Glp-1 Receptor Agonist Market Size
Figure 2020-2030 Europe Glp-1 Receptor Agonist Market Size and CAGR
Table 2020-2030 Europe Glp-1 Receptor Agonist Market Size by Application
Table 2020-2025 Europe Glp-1 Receptor Agonist Key Players Revenue
Table 2020-2025 Europe Glp-1 Receptor Agonist Key Players Market Share
Table 2020-2030 Europe Glp-1 Receptor Agonist Market Size by Type
Table 2020-2030 Germany Glp-1 Receptor Agonist Market Size
Table 2020-2030 France Glp-1 Receptor Agonist Market Size
Table 2020-2030 United Kingdom Glp-1 Receptor Agonist Market Size
Table 2020-2030 Italy Glp-1 Receptor Agonist Market Size
Table 2020-2030 Spain Glp-1 Receptor Agonist Market Size
Table 2020-2030 Belgium Glp-1 Receptor Agonist Market Size
Table 2020-2030 Netherlands Glp-1 Receptor Agonist Market Size
Table 2020-2030 Austria Glp-1 Receptor Agonist Market Size
Table 2020-2030 Poland Glp-1 Receptor Agonist Market Size
Table 2020-2030 Russia Glp-1 Receptor Agonist Market Size
Table 2020-2030 MEA Glp-1 Receptor Agonist Market Size
Figure 2020-2030 MEA Glp-1 Receptor Agonist Market Size and CAGR
Table 2020-2030 MEA Glp-1 Receptor Agonist Market Size by Application
Table 2020-2025 MEA Glp-1 Receptor Agonist Key Players Revenue
Table 2020-2025 MEA Glp-1 Receptor Agonist Key Players Market Share
Table 2020-2030 MEA Glp-1 Receptor Agonist Market Size by Type
Table 2020-2030 Egypt Glp-1 Receptor Agonist Market Size
Table 2020-2030 Israel Glp-1 Receptor Agonist Market Size
Table 2020-2030 South Africa Glp-1 Receptor Agonist Market Size
Table 2020-2030 Gulf Cooperation Council Countries Glp-1 Receptor Agonist Market Size
Table 2020-2030 Turkey Glp-1 Receptor Agonist Market Size
Table 2020-2025 Global Glp-1 Receptor Agonist Market Size by Region
Table 2020-2025 Global Glp-1 Receptor Agonist Market Size Share by Region
Table 2020-2025 Global Glp-1 Receptor Agonist Market Size by Application
Table 2020-2025 Global Glp-1 Receptor Agonist Market Share by Application
Table 2020-2025 Global Glp-1 Receptor Agonist Key Vendors Revenue
Figure 2020-2025 Global Glp-1 Receptor Agonist Market Size and Growth Rate
Table 2020-2025 Global Glp-1 Receptor Agonist Key Vendors Market Share
Table 2020-2025 Global Glp-1 Receptor Agonist Market Size by Type
Table 2020-2025 Global Glp-1 Receptor Agonist Market Share by Type
Table 2025-2030 Global Glp-1 Receptor Agonist Market Size by Region
Table 2025-2030 Global Glp-1 Receptor Agonist Market Size Share by Region
Table 2025-2030 Global Glp-1 Receptor Agonist Market Size by Application
Table 2025-2030 Global Glp-1 Receptor Agonist Market Share by Application
Table 2025-2030 Global Glp-1 Receptor Agonist Key Vendors Revenue
Figure 2025-2030 Global Glp-1 Receptor Agonist Market Size and Growth Rate
Table 2025-2030 Global Glp-1 Receptor Agonist Key Vendors Market Share
Table 2025-2030 Global Glp-1 Receptor Agonist Market Size by Type
Table 2025-2030 Glp-1 Receptor Agonist Global Market Share by Type

Companies Mentioned

  • Nordisk
  • Eli Lilly
  • Sanofi
  • AstraZeneca

Related Topics

Related Reports

GLP-1 Receptor Agonist Market Size, Share & Trends Analysis Report By Product (Ozempic, Zepbound), By Application (Diabetes, Obesity), By Route Of Administration (Parenteral, Oral), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

GLP-1 Receptor Agonist Market Size, Share & Trends Analysis Report By Product (Ozempic, Zepbound), By Application (Diabetes, Obesity), By Route Of Administration (Parenteral, Oral), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
GLP-1 Receptor Agonist - Global Strategic Business Report - Product Image

GLP-1 Receptor Agonist - Global Strategic Business Report

  • Report
  • 483 Pages
  • Global
From
GLP-1 Receptor Agonist Market by Drug Class, Drug Type, Route of Administration, Application, Distribution Channel - Global Forecast to 2030 - Product Image

GLP-1 Receptor Agonist Market by Drug Class, Drug Type, Route of Administration, Application, Distribution Channel - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
GLP-1 Receptor Agonist Market Report 2025 - Product Image

GLP-1 Receptor Agonist Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025 - Product Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.